COG Phase I Consortium — Arcadia, California

COG Phase I Consortium is a clinical research site located in Arcadia, California, United States 91006-3776.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

COG Phase I Consortium has participated in 10 clinical trials.

Therapeutic areas: Recurrent Childhood Acute Lymphoblastic Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Childhood Myelodysplastic Syndromes.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for COG Phase I Consortium?

COG Phase I Consortium has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has COG Phase I Consortium conducted?

COG Phase I Consortium has 10 clinical trials on record. Their work covers Recurrent Childhood Acute Lymphoblastic Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Childhood Myelodysplastic Syndromes.

Is COG Phase I Consortium accredited by Crixeo Health?

COG Phase I Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about COG Phase I Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.